Evidence map›Paper›PMID 25076493›Full record

ArticlePloS one2014

Can male circumcision have an impact on the HIV epidemic in men who have sex with men?

Steven M Goodreau, Nicole B Carnegie, Eric Vittinghoff, Javier R Lama, Jonathan D Fuchs, Jorge Sanchez, Susan P Buchbinder

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Steven M GoodreauUniversity of Washington, Seattle, Washington, United States of America.
Nicole B CarnegieHarvard School of Public Health, Boston, Massachusetts, United States of America.
Eric VittinghoffUniversity of California San Francisco, San Francisco, California, United States of America.
Javier R LamaAsociación Civil Impacta Salud y Educación, Lima, Perú
Jonathan D FuchsSan Francisco Department of Public Health, California, United States of America.
Jorge SanchezAsociación Civil Impacta Salud y Educación, Lima, Perú
Susan P BuchbinderSan Francisco Department of Public Health, California, United States of America.
Asociación Civil Impacta Salud y Educación · PESan Francisco Department of Public Health · USUniversity of California, San Francisco · USUniversity of Washington · US

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
Methods and Data CoreR24HD042828 · NICHD · UNIVERSITY OF WASHINGTON · PI TOLNAY, STEWART E · 2002 to 2016
$9.3M
San Francisco Vaccine and Prevention UnitU01AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI BUCHBINDER, SUSAN · 2007 to 2011
$7.3M
Acylovir to prevent HIV acquisition in HSV-2+personsR01AI052054 · NIAID · UNIVERSITY OF WASHINGTON · PI CELUM, CONNIE L · 2002 to 2004
$6.7M
Prevention Umbrella for MSM in the AmericasR01AI083060 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI BUCHBINDER, SUSAN · 2009 to 2012
$3.7M
Methods to Advance the HIV Prevention Research AgendaR37AI051164 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEGRUTTOLA, VICTOR GERARD · 2012 to 2019
$3.3M
Statistical Methods for Network EpidemiologyR01HD068395 · NICHD · UNIVERSITY OF WASHINGTON · PI MORRIS, WANDA MARTINA · 2011 to 2015
$3.0M
NIAID NIH HHS R01 AI052054NIAID NIH HHS R01 AI083060NIAID NIH HHS R01 AI52054NIAID NIH HHS R37 AI051164NIAID NIH HHS UM1 AI069496NICHD NIH HHS R01 HD068395NICHD NIH HHS R24 HD042828NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

backgroundThree trials have demonstrated the prophylactic effect of male circumcision (MC) for HIV acquisition among heterosexuals, and MC interventions are underway throughout sub-Saharan Africa. Similar efforts for men who have sex with men (MSM) are stymied by the potential for circumcised MSM to acquire HIV easily through receptive sex and transmit easily through insertive sex. Existing work suggests that MC for MSM should reach its maximum potential in settings where sexual role segregation is historically high and relatively stable across the lifecourse; HIV incidence among MSM is high; reported willingness for prophylactic circumcision is high; and pre-existing circumcision rates are low. We aim to identify the likely public health impact that MC interventions among MSM would have in one setting that fulfills these conditions-Peru-as a theoretical upper bound for their effectiveness among MSM generally. METHODS AND

findingsWe use a dynamic, stochastic sexual network model based in exponential-family random graph modeling and parameterized from multiple behavioral surveys of Peruvian MSM. We consider three enrollment criteria (insertive during 100%, >80% or >60% of UAI) and two levels of uptake (25% and 50% of eligible men); we explore sexual role proportions from two studies and different frequencies of switching among role categories. Each scenario is simulated 10 times. We estimate that efficiency could reach one case averted per 6 circumcisions. However, the population-level impact of an optimistic MSM-MC intervention in this setting would likely be at most ∼5-10% incidence and prevalence reductions over 25 years.

conclusionsRoll-out of MC for MSM in Peru would not result in a substantial reduction in new HIV infections, despite characteristics in this population that could maximize such effects. Additional studies are needed to confirm these results for other MSM populations, and providers may consider the individual health benefits of offering MC to their MSM patients.

Indexed as

Circumcision, MaleHomosexuality, MaleDisease OutbreaksHIV InfectionsHumansMaleModels, StatisticalPeru

Identifiers

PMID25076493
PMCPMC4116164
OpenAlexW2169572236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.